Literature DB >> 28982904

Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.

Shozo Ide1, Yuji Toiyama2, Yoshinaga Okugawa1, Satoshi Oki1, Hiromi Yasuda1, Hiroyuki Fujikawa1, Shigeyuki Yoshiyama1, Junitiro Hiro1, Minako Kobayashi1, Masaki Ohi1, Toshimitsu Araki1, Masato Kusunoki1.   

Abstract

BACKGROUND/AIM: This study was designed to evaluate the clinical significance of the C-reactive protein-to-albumin ratio (CAR) in patients with rectal cancer undergoing preoperative chemoradiotherapy (CRT) followed by surgery. PATIENTS AND METHODS: This retrospective study evaluated the correlation between CAR and prognosis in 115 patients with locally advanced rectal cancer. We also carried out subgroup analyses limited to patients with low modified Glasgow prognosis score (mGPS) (score 0) or pathological TNM stage I-II [ypN(-)].
RESULTS: CAR exhibited significant relationships with sex, tumor invasion, recurrence, serum carcinoembryonic antigen, and mGPS. Elevated CAR was an independent prognostic factor for overall survival (OS) and disease-free survival (DFS) among all patients. Elevated CAR also predicted poor OS and DFS in patients with pathological TNM stage I-II [ypN(-)] and low mGPS score.
CONCLUSION: CAR is a promising predictor of survival and recurrence in patients with rectal cancer treated by CRT. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  C-reactive protein-to-albumin ratio; Rectal cancer; chemoradiotherapy; prognosis

Mesh:

Substances:

Year:  2017        PMID: 28982904     DOI: 10.21873/anticanres.12022

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Modified neutrophil-platelet score as a promising marker for stratified surgical and oncological outcomes of patients with gastric cancer.

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Akira Yamamoto; Yusuke Omura; Kurando Kusunoki; Chengzeng Yin; Shozo Ide; Takahito Kitajima; Yuki Koike; Hiroyuki Fujikawa; Hiromi Yasuda; Yoshiki Okita; Junichiro Hiro; Shigeyuki Yoshiyama; Masaki Ohi; Toshimitsu Araki; Masato Kusunoki
Journal:  Surg Today       Date:  2019-09-04       Impact factor: 2.549

2.  Correlation between C-reactive protein/albumin ratio and prognosis in patients with lung adenocarcinoma.

Authors:  Zheng Jia-Min; Dai Wei; Lu Ye; Pan Xiang-Tao
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

3.  Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma.

Authors:  Takehiro Otoshi; Yuki Kataoka; Sawako Kaku; Reika Iki; Masataka Hirabayashi
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

4.  Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Hiroyuki Fujikawa; Mikio Kawamura; Hiromi Yasuda; Takeshi Yokoe; Ikuyo Mochiki; Yoshiki Okita; Masaki Ohi; Kaname Nakatani
Journal:  Surg Today       Date:  2021-05-05       Impact factor: 2.549

5.  Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.

Authors:  Xin Lu; Wanying Guo; Wei Xu; Xuelei Zhang; Zhijie Shi; Leizhen Zheng; Wenzhao Zhao
Journal:  Cancer Manag Res       Date:  2018-12-24       Impact factor: 3.989

6.  Novel Model to Predict the Prognosis of Patients with Stage II-III Colon Cancer.

Authors:  Yansong Xu; Fangfang Liang; Yi Chen; Zhen Wang; Huage Zhong; Weizhong Tang
Journal:  Biomed Res Int       Date:  2020-11-22       Impact factor: 3.411

7.  The predictive value of preoperative neutrophil-lymphocyte ratio (NLR) on the recurrence of the local pigmented villonodular synovitis of the knee joint.

Authors:  Guanglei Zhao; Jin Wang; Jun Xia; Yibing Wei; Siqun Wang; Gangyong Huang; Feiyan Chen; Jie Chen; Jingsheng Shi; Yuanqing Yang
Journal:  BMC Musculoskelet Disord       Date:  2018-09-19       Impact factor: 2.362

Review 8.  C-Reactive Protein to Albumin Ratio in Colorectal Cancer: A Meta-Analysis of Prognostic Value.

Authors:  Qiang-Ping Zhou; Xiu-Jiang Li
Journal:  Dose Response       Date:  2019-11-20       Impact factor: 2.658

Review 9.  Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Nanping Lin; Jingrong Li; Qiao Ke; Lei Wang; Yingping Cao; Jingfeng Liu
Journal:  Dis Markers       Date:  2020-09-02       Impact factor: 3.434

Review 10.  Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.

Authors:  Chun-Kai Liao; Yen-Lin Yu; Yueh-Chen Lin; Yu-Jen Hsu; Yih-Jong Chern; Jy-Ming Chiang; Jeng-Fu You
Journal:  World J Surg Oncol       Date:  2021-05-01       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.